Biotest Aktiengesellschaft (ETR:BIO – Get Free Report) shares were down 0.5% during trading on Wednesday . The company traded as low as €41.00 ($43.62) and last traded at €41.40 ($44.04). Approximately 1,000 shares traded hands during trading, a decline of 48% from the average daily volume of 1,927 shares. The stock had previously closed at €41.60 ($44.26).
Biotest Aktiengesellschaft Price Performance
The company has a market cap of $819.31 million, a price-to-earnings ratio of 9.98 and a beta of 0.24. The company has a fifty day simple moving average of €41.70 and a two-hundred day simple moving average of €41.65. The company has a quick ratio of 1.66, a current ratio of 2.45 and a debt-to-equity ratio of 116.50.
Biotest Aktiengesellschaft Company Profile
Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through three segments: European Union, Rest of the World, and Stateless. The company specializes primarily in the therapeutic areas of clinical immunology, haematology, and intensive care medicine.
Further Reading
- Five stocks we like better than Biotest Aktiengesellschaft
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Rocket Lab is the Right Stock for the Right Time
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Biotest Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotest Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
